In the BioHarmony Drug Report Database

"Preview" Icon

Icosapent ethyl

Vascepa, Vazkepa (icosapent ethyl) is a small molecule pharmaceutical. Icosapent ethyl was first approved as Vascepa on 2012-07-26. It has been approved in Europe to treat dyslipidemias. Vascepa’s patents are valid until 2033-06-28 (FDA).

 

Trade Name

 

Vazkepa
 

Common Name

 

icosapent ethyl
 

ChEMBL ID

 

CHEMBL2095209
 

Indication

 

dyslipidemias
 

Drug Class

 

Antilipemic Agents

Image (chem structure or protein)

Icosapent ethyl structure rendering